Your browser is old and is not supported. Upgrade for better security.


Human's best science for human's best friend 👨🏻‍🔬 🧬 🐶

Last Funded July 2021


raised from 1,220 investors
Pitch Video
Investor Panel


🐕We’re developing a cost effective cell therapy to cure cancer in dogs. It's proven in humans.
🐶Your funding goes DIRECTLY to our pilot trials in dogs with cancer
$150,000+ committed outside Wefunder during this round
🐩Awarded $394,000 in grant funding to date, including a National Science Foundation Phase I SBIR
🐶 Booming companion animal market. Over 90M dogs in the USA, $100B+ yearly spend in the space.
🐩6M dogs die from cancer each year and we're on track to get to market by 2024 to help
🐕We're a team of world leading experts in gene editing, immunotherapy, and veterinary oncology.

Our Team

Dogs are part of the family and we don't feel that the current care they get is up to par; they deserve the same technological advances in healthcare that their humans get. Using our expertise in gene editing, we can bring innovation to the veterinary market that has never before been possible.

We're using human's best science for human's best friend

LEAH Labs is the first company utilizing gene editing to engineer living therapies for dogs. Using our proprietary technology, we give living cells the genetic information to seek out and destroy cancer.

We’re using human’s best science, for human’s best friend.